Press release
Hematopoietic Stem Cell Transplantation Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Sanofi, Actinium Pharma, Medexus Pharma, medac Pharma, Actinium Pharma
DelveInsight's "Hematopoietic Stem Cell Transplantation Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Hematopoietic Stem Cell Transplantation, historical and forecasted epidemiology as well as the Hematopoietic Stem Cell Transplantation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Hematopoietic Stem Cell Transplantation market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to 2034. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Hematopoietic Stem Cell Transplantation market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hematopoietic Stem Cell Transplantation Market Insights [https://www.delveinsight.com/sample-request/hematopoietic-stem-cell-transplantation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Hematopoietic Stem Cell Transplantation Market Report:
*
The Hematopoietic Stem Cell Transplantation market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
According to DelveInsight's estimates, hematopoietic stem cell transplantation (HSCT) cases in the United States made up more than 40% of the total prevalent cases reported across the 7MM in 2023.
*
HSCT primarily consists of two types of transplants: autologous and allogeneic. According to DelveInsight's consultant estimates, the majority of HSCT cases were autologous, accounting for approximately 60% of the cases in the United States in 2023.
*
Multiple myeloma/plasma cell disorders represent the largest prevalent patient population undergoing HSCT procedures across all the evaluated indications in the 7MM, except for Japan, where AML patients account for the majority of HSCT cases.
*
The United States accounts for about 65% of the hematopoietic stem cell transplantation market, exceeding the market sizes of the EU4, the UK, and Japan.
*
Iomab-B (I-131 apamistamab) is projected to achieve the largest market size among emerging therapies by 2034.
*
Key Hematopoietic Stem Cell Transplantation Companies: Sanofi, Actinium Pharmaceuticals, Medexus Pharmaceuticals /medac Pharma, Actinium Pharmaceuticals, BioLineRx, Medexus pharma, and others
*
Key Hematopoietic Stem Cell Transplantation Therapies: MOZOBIL (plerixafor), Iomab-B (CD45) (apamistamab-I-131), TRECONDI (treosulfan), Treosulfan, and others
*
The Hematopoietic Stem Cell Transplantation epidemiology based on gender analyzed that in the United States in 2021 was observed in patients with age 40 years and above, followed by 18-39 years and below 18 years
Hematopoietic Stem Cell Transplantation Overview
Hematopoietic stem cell transplantation (HSCT) administers healthy hematopoietic stem cells (HSC) to patients with defective or depleted bone marrow. This improves bone marrow function and, depending on the disease being treated, leads to either the destruction of malignant tumor cells or the generation of functional cells that can replace the dysfunctional ones, as in the case of immune-deficiency syndromes, hemoglobinopathies, and other diseases.
Get a Free sample for the Hematopoietic Stem Cell Transplantation Market Report:
https://www.delveinsight.com/report-store/hematopoietic-stem-cell-transplantation-market [https://www.delveinsight.com/report-store/hematopoietic-stem-cell-transplantation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Hematopoietic Stem Cell Transplantation Market
The dynamics of the Hematopoietic Stem Cell Transplantation market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2020-2034.
"Recent advances in transplant immunology, supportive care and management of complications, and reduced toxicity conditioning have made Hematopoietic Stem Cell Transplantation an increasingly efficacious curative modality. More recently, immunotherapy is extending the curative potential of harnessing the immune system against cancer, to reduce the toxicities normally associated with conventional Hematopoietic Stem Cell Transplantation"
Hematopoietic Stem Cell Transplantation Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Hematopoietic Stem Cell Transplantation Epidemiology Segmentation:
The Hematopoietic Stem Cell Transplantation market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Hematopoietic Stem Cell Transplantation
*
Prevalent Cases of Hematopoietic Stem Cell Transplantation by severity
*
Gender-specific Prevalence of Hematopoietic Stem Cell Transplantation
*
Diagnosed Cases of Episodic and Chronic Hematopoietic Stem Cell Transplantation
Download the report to understand which factors are driving Hematopoietic Stem Cell Transplantation epidemiology trends @ Hematopoietic Stem Cell Transplantation Epidemiological Insights [https://www.delveinsight.com/sample-request/hematopoietic-stem-cell-transplantation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Hematopoietic Stem Cell Transplantation Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hematopoietic Stem Cell Transplantation market or expected to get launched during the study period. The analysis covers Hematopoietic Stem Cell Transplantation market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Hematopoietic Stem Cell Transplantation Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Hematopoietic Stem Cell Transplantation Therapies and Key Companies
*
MOZOBIL (plerixafor): Sanofi
*
Iomab-B (CD45) (apamistamab-I-131): Actinium Pharmaceuticals
*
TRECONDI (treosulfan): Medexus Pharmaceuticals /medac Pharma
*
Iomab-B: Actinium Pharmaceuticals
*
Motixafortide: BioLineRx
*
Treosulfan: Medexus pharma
To know more about Hematopoietic Stem Cell Transplantation treatment, visit @ Hematopoietic Stem Cell Transplantation Medications [https://www.delveinsight.com/sample-request/hematopoietic-stem-cell-transplantation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Hematopoietic Stem Cell Transplantation Market Strengths
*
Hematopoietic Stem Cell Transplantation is the only potentially curative treatment for patients with chemotherapy-resistant hematological malignancies, which are usually fatal without treatment
*
Hematopoietic Stem Cell Transplantation is a widely accepted therapeutic modality for several malignant, hematologic, immunologic, and genetic diseases. This therapy consists of the intravenous infusion of hematopoietic progenitor cells to reestablish marrow function in patients with damaged or defective bone marrow
Hematopoietic Stem Cell Transplantation Market Barriers
*
Improved outcomes of Hematopoietic Stem Cell Transplantation are due to improvements in tissue typing, prophylaxis against viral and fungal infection, immunosuppressive drugs, and supportive care
*
Recognition of risk factors for complications allows the design of risk-specific supportive-care regimens that reduce the incidence of transplantation morbidity and mortality
Scope of the Hematopoietic Stem Cell Transplantation Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Hematopoietic Stem Cell Transplantation Companies: Sanofi, Actinium Pharmaceuticals, Medexus Pharmaceuticals /medac Pharma, Actinium Pharmaceuticals, BioLineRx, Medexus pharma, and others
*
Key Hematopoietic Stem Cell Transplantation Therapies: MOZOBIL (plerixafor), Iomab-B (CD45) (apamistamab-I-131), TRECONDI (treosulfan), Treosulfan, and others
*
Hematopoietic Stem Cell Transplantation Therapeutic Assessment: Hematopoietic Stem Cell Transplantation current marketed and Hematopoietic Stem Cell Transplantation emerging therapies
*
Hematopoietic Stem Cell Transplantation Market Dynamics: Hematopoietic Stem Cell Transplantation market drivers and Hematopoietic Stem Cell Transplantation market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Hematopoietic Stem Cell Transplantation Unmet Needs, KOL's views, Analyst's views, Hematopoietic Stem Cell Transplantation Market Access and Reimbursement
Discover more about therapies set to grab major Hematopoietic Stem Cell Transplantation market share @ Hematopoietic Stem Cell Transplantation market forecast [https://www.delveinsight.com/sample-request/hematopoietic-stem-cell-transplantation-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Hematopoietic Stem Cell Transplantation Market Report Introduction
2. Executive Summary for Hematopoietic Stem Cell Transplantation
3. SWOT analysis of Hematopoietic Stem Cell Transplantation
4. Hematopoietic Stem Cell Transplantation Patient Share (%) Overview at a Glance
5. Hematopoietic Stem Cell Transplantation Market Overview at a Glance
6. Hematopoietic Stem Cell Transplantation Disease Background and Overview
7. Hematopoietic Stem Cell Transplantation Epidemiology and Patient Population
8. Country-Specific Patient Population of Hematopoietic Stem Cell Transplantation
9. Hematopoietic Stem Cell Transplantation Current Treatment and Medical Practices
10. Hematopoietic Stem Cell Transplantation Unmet Needs
11. Hematopoietic Stem Cell Transplantation Emerging Therapies
12. Hematopoietic Stem Cell Transplantation Market Outlook
13. Country-Wise Hematopoietic Stem Cell Transplantation Market Analysis (2020-2034)
14. Hematopoietic Stem Cell Transplantation Market Access and Reimbursement of Therapies
15. Hematopoietic Stem Cell Transplantation Market Drivers
16. Hematopoietic Stem Cell Transplantation Market Barriers
17. Hematopoietic Stem Cell Transplantation Appendix
18. Hematopoietic Stem Cell Transplantation Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hematopoietic-stem-cell-transplantation-market-growth-to-accelerate-in-forecast-period-20242034-delveinsight-analyzes-sanofi-actinium-pharma-medexus-pharma-medac-pharma-actinium-pharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hematopoietic Stem Cell Transplantation Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Sanofi, Actinium Pharma, Medexus Pharma, medac Pharma, Actinium Pharma here
News-ID: 3698610 • Views: …
More Releases from ABNewswire
Exploring the Impact of U.S. Government Shutdown on the Global Markets - An Excl …
Image: https://www.abnewswire.com/upload/2025/11/6ab92174e3dc0ee6c1bfafc8e655cfb4.jpg
A shutdown of the U.S. federal government, when Congress fails to pass spending legislation and many agencies cease non-essential operations, poses a material risk to the economy. But when viewed through the lens of market history and global asset flows, the evidence suggests that such shutdowns are often absorbed by the markets and, in several ways, may present tactical opportunities for globally diversified investors.
1. What a U.S. Government Shutdown…
Green Ammonia Market size growing at CAGR of 82.47% by 2030 | Rising Fertilizer …
The latest research by Mordor Intelligence covers the "Green Ammonia Market," delivering insights into market dynamics, drivers of growth, and long-term forecasts.
Green Ammonia Market Overview:
The global green ammonia market is expanding steadily as countries accelerate the shift toward low-carbon fertilizer, marine fuel, power generation, and hydrogen transport solutions. The green ammonia market [https://www.mordorintelligence.com/industry-reports/green-ammonia-market?utm_source=abnewswire] size is expected to grow from 0.27 million tons in 2025 to 5.41 million tons by 2030,…
Point of Care Diagnostics Market to Reach USD 84.93 Billion by 2030, Driven by R …
Mordor Intelligence has published a new report on Point Of Care Diagnostics Market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
The Point Of Care Diagnostics Market [https://www.mordorintelligence.com/industry-reports/point-of-care-diagnostics?utm_source=abnewswire] size is estimated at USD 53.63 billion in 2025, and is expected to reach USD 84.93 billion by 2030, at a CAGR of 9.63% during the forecast period (2025-2030). The market's growth is fueled by the increasing need for rapid,…
Enteral Feeding Devices Market Forecast to Reach USD 4.94 Billion by 2030, Drive …
Mordor Intelligence has published a new report on enteral feeding devices market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
The enteral feeding devices market [https://www.mordorintelligence.com/industry-reports/enteral-feeding-devices-market?utm_source=abnewswire] is projected to grow from approximately USD 3.72 billion in 2025 to USD 4.94 billion by 2030, according to a recent report by Mordor Intelligence. The growth reflects a compound annual growth rate (CAGR) of around 5.84 percent, driven primarily by technological…
More Releases for Hematopoietic
Rising Blood Cancer Incidence Fuels Growth In The Hematopoietic Stem Cell Transp …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Hematopoietic Stem Cell Transplantation Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market centered around hematopoietic stem cell transplantation has experienced robust expansion lately, projecting a rise from a valuation of $4.68 billion in 2024 to $5.1 billion in 2025, reflecting a compound annual…
Emerging Hematopoietic Stem Cell Transplantation Market Trends: Product Approval …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Hematopoietic Stem Cell Transplantation Market Size Growth Forecast: What to Expect by 2025?
The market for hematopoietic stem cell transplantation has shown robust growth in the past few years. It is projected to expand from $4.68 billion in 2024 to $5.12 billion in 2025, with a compound annual growth…
Hematopoietic Agents Market Size And Global Industry Forecast 2034
" The hematopoietic agents market is projected to reach approximately $20.5 billion in value by 2024, driven by an increasing prevalence of hematologic disorders and an aging global population. From 2025 to 2034, the market is expected to expand at a robust CAGR of 6.2%, potentially reaching around $36.5 billion by the end of this period. "
Exactitude Consultancy., Ltd. released a research report titled "Hematopoietic Agents Market". This report covers…
Hematopoietic Stem Cell Transplantation Market Analysis and Forecast 2024-2031
The global hematopoietic stem cell transplantation market is anticipated to grow at a considerable CAGR during the forecast. The Major driver in the hematopoietic stem cell transplantation market is the growing network of hematopoietic stem cell transplantation organizations that have reached across the globe and have been seen by an NGO called the Worldwide Network for Blood and Marrow Transplantation Group officially affiliated with the World Health Organization. The growing…
Hematopoietic Stem Cell Transplantation Market Analysis and Forecast 2024-2031
The global hematopoietic stem cell transplantation market is anticipated to grow at a considerable CAGR during the forecast. The Major driver in the hematopoietic stem cell transplantation market is the growing network of hematopoietic stem cell transplantation organizations that have reached across the globe and have been seen by an NGO called the Worldwide Network for Blood and Marrow Transplantation Group officially affiliated with the World Health Organization. The growing…
Hematopoietic Agents Market Estimated to Flourish by 2024
Hematopoiesis is a process of continuous replacement of most mature blood cells. New produced blood cells must be adequate to meet the basic demand of body. Hematopoiesis process needs an ample supply of minerals (e.g., iron, copper, and cobalt) and vitamins (e.g., vitamin B12, folic acid, ascorbic acid, pyridoxine, and riboflavin). Normal hematopoiesis process produces more than 400 billion blood cells each day, this production can be increased several-fold with…
